At the recent Advisory Committee to the NIH Director (ACD), one of NIH’s newest ACD working groups looking at the issue of Novel Alternative Methods (NAMs) presented a status update. NIH has published a request for information (RFI) to help inform the ACD working group’s deliberations. In particular, NIH is interested in learning from the research community how NAMs are currently being used to study human biology, circuits, systems, and disease states; approaches for catalyzing the development and validation of new NAMs; and strategies for maximizing the value of NAMs in research.
Submit your response to the RFI by August 16, 2023. Your feedback is important and helps shape NIH policy.